Photo

Photo detail

Stories this photo appears in:

Peregrine Drops Trial; Shares Crash

Shares of Tustin-based drug developer Peregrine Pharmaceuticals Inc. fell sharply today, a day after the company said it would discontinue a third-phase clinical trial.

Tease photo

FDA Gives Peregrine Drug Fast Track Status

Shares of Tustin-based drug developer Peregrine Pharmaceuticals Inc. soared in afternoon trading Monday on word that it received fast-track status from the Food and Drug Administration for its lead product candidate.

Tease photo

FDA Gives Peregrine Drug Fast Track Status

Shares of Tustin-based drug developer Peregrine Pharmaceuticals Inc. soared in afternoon trading Monday on word that it received fast-track status from the Food and Drug Administration for its lead product candidate.

Tease photo

Peregrine Stumbles after Study Stopped

Tustin-based Peregrine Pharmaceuticals Inc.’s shares plummeted today after it said it would halt a clinical trial involving its lung cancer drug candidate.

Tease photo